Optimal ATP settings for new ICDs in heart disease patients
Official title: Optimal ATP Settings in the VT Zone for New Implantable Cardioverter Defibrillator (ICD) Implantation (DAN-ATP)
Run by Copenhagen University Hospital, Rigshospitalet · NCT07354347 · Data updated 2026-11-12
This trial tests whether Burst or Ramp ATP settings in the VT zone of a new ICD help patients with heart disease.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 3980 (estimated) |
| Sponsor | Copenhagen University Hospital, Rigshospitalet Academic / other |
| Locations | 1 site (Copenhagen, Dr.) |
| Status | Recruiting |
| Started | February 1, 2026 |
| Main results expected | July 31, 2041 |
| Study ends | July 31, 2041 |
| Registry record updated | September 4, 2026 |
| Trial ID | NCT07354347 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Patients receiving a new ICD for either primary or secondary prevention of sudden cardiac events due to heart disease.
✕Probably not a fit
Patients may not benefit if their VT physiology or comorbidities render ATP settings less effective for their rhythm patterns.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pragmatic, cluster-randomized trial compares two ATP programming strategies (Burst vs Ramp) for ventricular tachyarrhythmias in patients receiving a new ICD. Hospitals are randomized to one strategy for four months at a time, with the chosen approach followed for the device’s lifetime unless reprogrammed. The study focuses on ATP delivery in the VT zone defined as roughly 180–249 (up to 269) beats per minute. Outcomes are driven by the occurrence of ATP events over time, aiming to determine which setting reduces VT-related interventions. Participation is offered to patients undergoing ICD implantation for primary or secondary protection, with opt-out allowed.
Why it matters
Potential benefit: If successful, the preferred ATP setting could reduce VT events and improve ICD performance and patient comfort.
How similar studies have gone: Prior ATP programming work has shown variability in performance; this pragmatic trial tests a specific two-option strategy in a real-world setting.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: \- ICD implantation for primary or secondary prophylactic indication Exclusion Criteria: * None * Patients can actively opt out of participation in the study
Where it's running
-
The Heart Center, Rigshospitalet
Copenhagen, Dr., Denmark Recruiting
Study contacts
- Study coordinator: Bo G Winkel, MD, PhD
- Email: bo.winkel@regionh.dk
- Phone: +4535459759
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Differentiating heart disease in autoimmune vs. type 2 diabetes
This study tests whether adult-onset autoimmune diabetes (AID/LADA) and type 2 diabetes (T2D) differ in how diabetic heart disease develops, using advanced heart imaging in people with AID, T2D, and healthy controls.
-
Cardiac Function and Anesthesia Depth During Heart Surgery
This study tests whether deeper or lighter anesthesia affects heart function during elective heart surgery with bypass in adults.
-
Upper-extremity exercise options for people with heart failure and implanted devices
This study tests different upper-extremity exercise programs to see which helps people with heart failure and implanted defibrillators or CRT devices improve arm function.
-
DigitHeart Echo: predicting heart ultrasound findings from a smartphone photo of your ECG
This test checks whether a smartphone app can predict echocardiogram findings from a photo of a 12‑lead ECG in adults scheduled for echocardiography.
-
Using blood flow measurements during bypass surgery to predict graft openness and recovery
This trial will test whether using a device that measures blood flow during coronary bypass surgery helps surgeons ensure grafts stay open and improves recovery for adults having their first non-emergency multivessel CABG.
-
Tiny ultrasound bubbles as an alternative to catheters for measuring pressures inside the heart
This will test whether injecting tiny ultrasound bubbles can estimate heart filling pressures in people who are having a cardiac catheterisation.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.